Dr. Monohan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Rose Street
CC446 Roach Bldg UK Hematology Clinic
Lexington, KY 40536Phone+1 859-257-6006Fax+1 859-257-6002
Summary
- Dr. Gregory Monohan is an oncologist in Lexington, KY and is affiliated with University of Kentucky Albert B. Chandler Hospital. He received his medical degree from University of Kentucky College of Medicine and has been in practice 17 years. He specializes in hematologic oncology and is experienced in hematologic oncology and stem cell transplantation.
Education & Training
University of Kentucky College of MedicineFellowship, Hematology and Medical Oncology, 2003 - 2006
Indiana University School of MedicineResidency, Internal Medicine, 2000 - 2003
University of Kentucky College of MedicineClass of 2000
Certifications & Licensure
KY State Medical License 2003 - 2025- American Board of Internal Medicine Hematology
Clinical Trials
- Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) Start of enrollment: 2010 May 01
Publications & Presentations
PubMed
- 48 citationsPhase 2 Study of Venetoclax Plus Carfilzomib and Dexamethasone in Patients with Relapsed/Refractory Multiple MyelomaLuciano J. Costa, Faith E. Davies, Gregory Monohan, Tibor Kovacsovics, Nicholas Burwick
Blood Advances. 2018-11-29 - 6 citationsTen-year survival outcomes for patients with early stage classical Hodgkin lymphoma: An analysis from Kentucky Cancer Registry.Zin W. Myint, Runa Shrestha, Salahuddin Siddiqui, Stacey Slone, Bin Huang
Hematology/oncology and Stem Cell Therapy. 2020-03-01 - 27 citationsPhase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma.Kevin R. Kelly, Jonathan W. Friedberg, Steven I. Park, Kevin T. McDonagh, John Hayslip
Clinical Cancer Research. 2018-12-15
Journal Articles
- Age Adjusted Hematopoietic Stem Cell Transplant Comorbidity Index Predicts Survival in a T-cell Depleted Cohort☆Swati Yalamanchi, Hayder Saeed, Dianna Howard, Gerhard C Hildebrandt, Roger Herzig, Gregory Monohan, ScienceDirect
- Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/vincristine in Relapsed/refractory Aggressive B-cell LymphomaDaniel Persky, Soham Puvvada, Catherine Spier, Gregory Monohan, Ari VanderWalde, Daruka Mahadevan, Clinical Cancer Research
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
